SV2A receptor agonist

This page covers all SV2A receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SV2A.

Targets

SV2A

Phase 3 pipeline (1)

• brivaracetam (BRV) tablet · UCB Biopharma SRL · Neurology
  Brivaracetam is a selective, high-affinity SV2A receptor agonist.

Patent intelligence

• sv2a receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates